RSV vaccine study for pregnant women in Belgium: safety hinges on vaccine familiarity

Vaccinopolis is recruiting 90 pregnant women for an RSV vaccine and antibody study, with safety protocols emphasized by experts. The risk profile depends on how well-established the vaccine is, and independent oversight is in place. This is a routine clinical trial announcement, not a market-moving event.